Isophane Protamine Recombinant Human Insulin(30R)(Zhuhai United)

精蛋白重组人胰岛素注射液(30R)(珠海联邦)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIsophane Protamine Recombinant Human Insulin(30R)(Zhuhai United)
Drug Alias Name精蛋白人胰岛素混合注射液(30R)精蛋白重组人胰岛素混合注射液30/70优思灵30RUSLIN30R
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesZhongshan Branch of Zhuhai United Laboratories Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhongshan Branch of Zhuhai United Laboratories Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A